Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Tulin Shekar"'
Autor:
Yaru Shi, Katrina M. Nolan, Robert L. Burton, Tulin Shekar, Rocio D. Murphy, Natalie Banniettis, Luwy Musey, Ulrike K. Buchwald
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
Pneumococcal serogroups consist of structurally related serotypes, and serotype-specific antibodies can cross-react against other serotypes within the same serogroup. Cross-reactivity of vaccine-induced serotype 6A antibodies, and, to a lesser extent
Externí odkaz:
https://doaj.org/article/67c29386504f4f9c9be3b03037d0927c
Autor:
Laura L. Hammitt, Dean Quinn, Ewa Janczewska, Francisco J. Pasquel, Richard Tytus, K. Rajender Reddy, Katia Abarca, Ilsiyar M. Khaertynova, Ron Dagan, Rachel Dawson, Jennifer McCauley, Tulin Shekar, Wei Fu, Alison Pedley, Tina Sterling, Gretchen Tamms, Luwy Musey, Ulrike K. Buchwald
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
Immunocompetent adults with certain medical and behavioral factors are at increased risk of pneumococcal disease. In some countries, sequential vaccination with 13-valent pneumococcal conjugate vaccine (PCV13) followed by 23-valent pneumococcal polys
Externí odkaz:
https://doaj.org/article/f875d2655e614b2e8e50c8bd1322293d
Autor:
Marissa Wilck, Oliver A Cornely, Per Ljungman, Catherine Cordonnier, Juan Diego Velez, Ron Dagan, Peter Richmond, Qiuxu Chen, Caroline Daus, Kateasha Geddie, Tina Sterling, Tulin Shekar, Luwy Musey, Ulrike K Buchwald
Publikováno v:
JAC-Antimicrobial Resistance. 5
Background Allogeneic haematopoietic cell transplant (allo-HCT) represents a definitive therapy for a variety of haematological diseases. Immunosuppressive therapy following allo-HCT and graft-versus-host disease (GVHD) render the patient susceptible
Autor:
Jakub K. Simon, Nina Breinholt Staerke, Maria Hemming-Harlo, Stacey Layle, Ron Dagan, Tulin Shekar, Alison Pedley, Patricia Jumes, Gretchen Tamms, Tina Sterling, Luwy Musey, Ulrike K. Buchwald
Publikováno v:
Simon, J K, Staerke, N B, Hemming-Harlo, M, Layle, S, Dagan, R, Shekar, T, Pedley, A, Jumes, P, Tamms, G, Sterling, T, Musey, L, Buchwald, U K & for the V114-020 PNEU-TRUE study group 2022, ' Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged ≥50 years : A randomized phase 3 trial (PNEU-TRUE) ', Vaccine, vol. 40, no. 9, pp. 1342-1351 . https://doi.org/10.1016/j.vaccine.2021.12.067
Background: Older adults are at risk of pneumococcal disease and associated morbidity and mortality. This phase 3 study (V114-020) assessed lot-to-lot consistency across safety and immunogenicity outcomes for V114, a 15-valent pneumococcal conjugate
Autor:
Robert Clifford, Heather L. Platt, Katrina M. Nolan, David Greenberg, Tulin Shekar, Camilo J. Acosta, Jianing Li, D Hurley, Shu-Chih Su, Nicola P. Klein, Richard D. McFetridge, Kara Bickham, Kim Hurtado, Bruce Tapiero, Luwy Musey
Publikováno v:
The Pediatric Infectious Disease Journal
Supplemental Digital Content is available in the text.
Background: Pneumococcal disease remains a public health priority worldwide. This phase 2 study (V114-008; NCT02987972; EudraCT 2016-001117-25) compared safety and immunogenicity of 2 clinic
Background: Pneumococcal disease remains a public health priority worldwide. This phase 2 study (V114-008; NCT02987972; EudraCT 2016-001117-25) compared safety and immunogenicity of 2 clinic
Autor:
Cindy Weinstein, Nicholas Ryan, Tulin Shekar, Davis Gates, Stephen J. Lane, Ioana Agache, Robert A. Nathan, Spiro Investigators
Publikováno v:
Journal of Allergy and Clinical Immunology. 143:1395-1402
The safety of long-acting β-agonists added to inhaled corticosteroids for the treatment of persistent asthma has been controversial.We sought to determine whether administering formoterol in combination with mometasone furoate increases the risk of
Publikováno v:
Pediatric Pulmonology. 52:310-318
SummaryObjectives Mometasone furoate (MF), delivered via dry-powder inhaler (DPI) QD in the evening (PM), is a treatment option for pediatric patients with asthma. We evaluated MF delivered via a metered-dose inhaler (MDI), in children ages 5–11 ye
Autor:
Kirill Zykov, Tina M. Sterling, Elizaveta Bitieva, Luwy Musey, Nikolay Ivanovich Briko, Tulin Shekar, Karen L. Ciprero, Jon E. Stek
Publikováno v:
Human Vaccines & Immunotherapeutics. 12:2142-2147
Pneumococcal infection is a major cause of pneumonia, bacteremia, and meningitis. Incidence of pneumococcal disease (PD) varies worldwide. The 23-valent pneumococcal polysaccharide vaccine (PPV23) displays an acceptable safety profile and has been de
Autor:
Ioana Agache, Tulin Shekar, Cindy Weinstein, Melanie Jones, Veerle Van de Velde, Stephen J. Lane, Robert A. Nathan, Xiaoli Zhang, Davis Gates, Nicholas Ryan, Carmen Antonio
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 8:1634-1644.e1
Because of historical safety concerns with the use of long-acting β-agonists (LABA) in asthma, step-down from inhaled corticosteroid (ICS)/LABA combination therapy to ICS monotherapy is recommended once asthma control is achieved.To evaluate the ben
Autor:
Ioana Agache, Robert A. Nathan, Tulin Shekar, Nicholas Ryan, Cindy Weinstein, Stephen J. Lane, Davis Gates, Xiaoli Zhang
Publikováno v:
Journal of Allergy and Clinical Immunology. 143:AB53